Overview

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The impact of sodium intake on plasma drug concentrations has previously been reported in the literature for verapamil and quinidine but, to the investigators' knowledge, never with renin-angiotensin system blockers such as AT1R antagonists and angiotensin converting enzyme inhibitors.
Phase:
Phase 1
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Atenolol
Candesartan
Candesartan cilexetil
Ramipril
Valsartan